Emtricitabine: A Viewpoint by Raymond F. Schinazi

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.22, 2003-01, pp. : 2425-2426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emtricitabine/Tenofovir Disoproxil Fumarate: A Viewpoint by Daniel Podzamczer

By Daniel Podzamczer

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2083-2084

Adis International

Access to resources Recommend Favorite

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Triple Combination Tablet: A Viewpoint by Jose R. Arribas

By Arribas Jose R.

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1513-1514

Adis International

Access to resources Recommend Favorite

Memantine: A Viewpoint by Hans Förstl

By Förstl H.

Drugs & Aging, Vol. 20, Iss. 6, 2003-01 ,pp. : 477-478

Adis International

Access to resources Recommend Favorite

Efavirenz/emtricitabine/tenofovir disoproxil fumarate: Psychosis due to efavirenz?: case report

Reactions Weekly, Vol. 1, Iss. 1434, 2013-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate

By Adis International Limited

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 160-161

Adis International

Access to resources Recommend Favorite